CIRCLE PHARMA
Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diverse macrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
CIRCLE PHARMA
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Therapeutics
Founded:
2012-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.circlepharma.com
Total Employee:
11+
Status:
Active
Contact:
650-392-0363
Email Addresses:
[email protected]
Total Funding:
117.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Euro WordPress 6.0 WP Rocket
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Current Advisors List
Current Employees Featured
Founder
Investors List
Nextech Invest
Nextech Invest investment in Series C - Circle Pharma
The Column Group
The Column Group investment in Series C - Circle Pharma
Pandect Bioventures
Pandect Bioventures investment in Series C - Circle Pharma
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series C - Circle Pharma
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series C - Circle Pharma
Pavillion Capital
Pavillion Capital investment in Series C - Circle Pharma
Euclidean Capital
Euclidean Capital investment in Series C - Circle Pharma
Nextech Invest
Nextech Invest investment in Series B - Circle Pharma
The Column Group
The Column Group investment in Series B - Circle Pharma
Berkeley Catalyst Fund (BCF)
Berkeley Catalyst Fund (BCF) investment in Series B - Circle Pharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-26 | Circle Pharma Appoints Paul Park, MBA, as its Chief Business Officer |
| 2021-07-12 | Circle Pharma Appoints Evelyn Wang, PhD as its Vice President, Translational Medicine |
Official Site Inspections
http://www.circlepharma.com
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
